MENU

Eureka projects

Bioactive alginates (low guluronate) to be produced in-vivo in bacteria, and by in-vitro epimerisation of high mannuronate alginates from seaweed or bacteria. They will be used for wound healing, health supportive fish feed, fish vaccines and also combined with biopolymers for enhanced performance.
Project ID: 
3354

Prototype hiv vaccines consisting of dna vectors that express either single hiv genes or artificial genes consisting of several genes and gene fragments will be tested for safety, immunogenicity and therapeutic effect in clinical trials and for a therapeutic effect in an animal model.
Project ID: 
3421

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.